Eswatini

Last Updated 17 January 2022.

1 Vaccine Approved for Use in Eswatini

• Oxford/AstraZeneca
  AZD1222

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 134 countries

  54 trials in 24 countries

  Approval Source: afro.who.int

  Non Replicating Viral Vector

1 Vaccine in Clinical Trials in Eswatini

• Moderna
  mRNA-1273

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 85 countries

  43 trials in 19 countries

  RNA